Mahuteau-Betzer; Florence

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mahuteau-Betzer; Florence.The latest application filed is for "phenyl-n-quinoline derivatives for treating a rna virus infection".

Company Profile

2.10.11

Mahuteau-Betzer; Florence - Saint Remy les Chevreuse FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
miRNA-124 as a biomarker Grant 11,441,181 - Tazi , et al. September 13, 2	2022-09-13
Phenyl-n-quinoline Derivatives For Treating A Rna Virus Infection App 20210309611 - SCHERRER; Didier ; et al.	2021-10-07
Aryl-n-aryl Derivatives For Treating A Rna Virus Infection App 20210300871 - SCHERRER; Didier ; et al.	2021-09-30
Aryl-n-aryl Derivatives For Treating A Rna Virus Infection App 20210122732 - SCHERRER; Didier ; et al.	2021-04-29
Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies Grant 10,654,813 - Tazi , et al.	2020-05-19
Chemical Molecules That Inhibit The Slicing Mechanism For Treating Diseases Resulting From Splicing Anomalies App 20190022037 - TAZI; Jamal ; et al.	2019-01-24
Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies Grant 10,130,595 - Tazi , et al. November 20, 2	2018-11-20
Compounds useful for treating diseases caused by retroviruses Grant 9,827,237 - Tazi , et al. November 28, 2	2017-11-28
Use of RBM39 as a biomaker Grant 9,556,489 - Tazi , et al. January 31, 2	2017-01-31
Chemical Molecules That Inhibit The Slicing Mechanism For Treating Diseases Resulting From Splicing Anomalies App 20160166519 - TAZI; Jamal ; et al.	2016-06-16
Compounds Useful For Treating Diseases Caused By Retroviruses App 20160151348 - TAZI; Jamal ; et al.	2016-06-02
Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies Grant 9,233,931 - Tazi , et al. January 12, 2	2016-01-12
miRNA-124 AS A BIOMARKER App 20150361491 - TAZI; Jamal ; et al.	2015-12-17
Use Of Rbm39 As A Biomarker App 20150072892 - Tazi; Jamal ; et al.	2015-03-12
Compounds derived from indole and pharmaceutical compositions containing them Grant 8,895,726 - Lejeune , et al. November 25, 2	2014-11-25
Chemical Molecules That Inhibit The Slicing Mechanism For Treating Diseases Resulting From Splicing Anomalies App 20140155436 - TAZI; Jamal ; et al.	2014-06-05
Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies Grant 8,604,063 - Tazi , et al. December 10, 2	2013-12-10
Chemical Molecules That Inhibit The Slicing Mechanism For Treating Diseases Resulting From Splicing Anomalies App 20110053975 - Tazi; Jamal ; et al.	2011-03-03
Novel Compounds Derived From Indole And Pharmaceutical Compositions Containing Them App 20110003843 - Lejeune; Fabrice ; et al.	2011-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.